Roumell Asset Management Continues Selling Transcept Pharmaceuticals

Roumell Asset Management, led by Jim Roumell, continues selling shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT). In a new filing, Roumell reported disposing 7,190 shares, reducing its exposure at the company to around 2.26 million shares. The fund sold the shares in three transactions, with the price being slightly above the $3.50 mark.

James Roumell

Disclosure: none

Recommended Reading:

Dialectic Capital Cuts Stake in Immersion Corporation

TPG Advisors Cuts Exposure at Armstrong World Industries

Jeff Ubben Helps to Recover Allison Transmission’s Face Value